Page last updated: 2024-09-05
lenalidomide and Atypical Chronic Myeloid Leukemia
lenalidomide has been researched along with Atypical Chronic Myeloid Leukemia in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Biemond, BJ | 1 |
Other Studies
1 other study(ies) available for lenalidomide and Atypical Chronic Myeloid Leukemia
Article | Year |
---|---|
Treatment considerations for primary myelofibrosis.
Topics: Anemia; Angiogenesis Inhibitors; Antineoplastic Agents; Humans; Lenalidomide; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Neovascularization, Pathologic; Primary Myelofibrosis; Prognosis; Risk Factors; Thalidomide | 2010 |